Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07281118 · ClinicalTrials.gov registry record · NA

Intercostal Cryoanalgesia in Double Lung Transplant Recipients

A NA study of Postoperative Pain Management, sponsored by University of California, Los Angeles.

Recruiting
Registry status
NA
Development phase
148
Enrollment target
3
Study locations

NCT07281118: Recruiting NA study of Postoperative Pain Management, sponsored by University of California, Los Angeles.

NCT07281118 is a NA study of Postoperative Pain Management that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 148 participants, above the 119-participant average among 7 other Postoperative Pain Management trials with a reported enrollment target (24% higher). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07281118, a NA study of Postoperative Pain Management, is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
NA
Development phase
148 participants
Enrollment target
3
Study locations

Study Summary

This study is testing a new way to help manage pain after a double lung transplant. Instead of relying only on strong pain medicines like opioids, doctors will use a cold-therapy probe during surgery to help numb the nerves near the incision. Researchers want to see if this method can reduce the need for opioids and improve recovery.

Primary Outcome

Total opioid use (oral morphine equivalents)

Interventions

  • DEVICE Atricure CryoSPHERE MAX Probe

Study Locations (3)

California

  • University of California Los Angeles - Los Angeles
  • University of California San Francisco - San Francisco

Texas

  • Baylor University - Waco

Trial Details

FieldValue
Enrollment Target 148 participants
Start Date 2025-12-16
Est. Completion 2027-11-24
Phase NA

What NCT07281118 shows while recruiting

NCT07281118 is an interventional study that assigns participants to a tested intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap, above the 119-participant average among 7 other Postoperative Pain Management trials with a reported enrollment target (24% higher).

The record links to 1 condition, with Postoperative Pain Management appearing as the primary indexed condition, and to 1 intervention - of which Atricure CryoSPHERE MAX Probe is the first listed.

NCT07281118 reports a single indexed study location in California, Texas.

Frequently Asked Questions

What is clinical trial NCT07281118 about?

NCT07281118 is a clinical study titled "Intercostal Cryoanalgesia in Double Lung Transplant Recipients". This study is testing a new way to help manage pain after a double lung transplant. Instead of relying only on strong pain medicines like opioids, doctors will use a cold-therapy probe during surgery to help numb the nerves near the incision. Researchers want to see if this method can reduce the nee...

What is the current status of trial NCT07281118?

This trial is currently recruiting. It is a NA study. The enrollment target is 148 participants. The study started on 2025-12-16. Estimated completion is 2027-11-24.

What conditions does trial NCT07281118 study?

This clinical trial studies the following conditions: Postoperative Pain Management.

What interventions are being tested in trial NCT07281118?

The interventions under investigation include: Atricure CryoSPHERE MAX Probe (DEVICE).

Who is sponsoring clinical trial NCT07281118?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07281118 being conducted?

This trial has 3 study locations across California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postoperative Pain Management

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00739362 · 148 participants · Phase 2

    Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment

  • NCT03161223 · 148 participants · Phase 1

    Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma

  • NCT03858231 · 148 participants · Phase 4

    Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery

  • NCT04486352 · 148 participants · Phase 1

    A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07281118, the US trial registry maintained by the National Library of Medicine. NCT07281118 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.